The Endocrine Disruption of Prenatal Phthalate Exposure in Mother and Offspring.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data reported in abstract
PubMed 32984231 · doi:10.3389/fpubh.2020.00366
What was done
The authors reviewed the literature regarding the endocrine-disrupting effects and associated clinical outcomes of prenatal phthalate exposure in pregnant women and offspring. The abstract does not specify literature search methods, dates, or study selection criteria.
What was found
No numerical data, effect estimates, or statistical values are reported in the abstract. The authors report that prenatal phthalate exposure disrupts maternal and offspring levels of thyroid hormones, sex hormones, and 25-hydroxyvitamin D. Reported associated conditions include preeclampsia, maternal glucose disorders, preterm birth, infant cryptorchidism, hypospadias, reduced neonatal anogenital distance, and growth restriction across infancy, childhood, and early adolescence, frequently displaying sex-specific patterns.
Why it matters
The review synthesizes human and mechanistic associations connecting gestational phthalate exposure to broad maternal and pediatric endocrine disturbances. This highlights the clinical and public health rationale for reducing exposure during pregnancy.
Limits
The abstract provides no quantitative data, sample sizes, or number of synthesized studies. As a narrative review, it lacks systematic search methodology, risk-of-bias evaluation, control for co-exposures or confounding in the underlying observational studies, and causal verification.
Cited by
- supports Maternal exposure to high levels of phthalates during pregnancy is linked to abnormal male fetal genital development, specifically hypospadias and undescended testicles (cryptorchidism).